(VIANEWS) – Ares Commercial Real Estate Corporation (ACRE), VOC Energy Trust Units of Beneficial Interest (VOC), AvalonBay Communities (AVB) are the highest payout ratio stocks on this list.
We have gathered information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Ares Commercial Real Estate Corporation (ACRE)
231.58% Payout Ratio
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, real estate preferred equity investments, mezzanine loans, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Ares Commercial Real Estate Corporation has a trailing twelve months EPS of $0.57.
PE Ratio
Ares Commercial Real Estate Corporation has a trailing twelve months price to earnings ratio of 15.11. Meaning, the purchaser of the share is investing $15.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.18%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 32.4% and positive 65% for the next.
2. VOC Energy Trust Units of Beneficial Interest (VOC)
100% Payout Ratio
VOC Energy Trust acquires and holds a term net profits interest of the net proceeds from production and sale of the interests in oil and natural gas properties in the states of Kansas and Texas. The company has an 80% term net profits interest of the net proceeds on the underlying properties. As of December 31, 2020, its underlying properties had interests in 470.3 net producing wells and 84,332 net acres; and had proved reserves of approximately 3.1 million barrels of oil equivalent (MMBoe) attributable to the portion of the Kansas underlying properties, and approximately 3.1 MMBoe attributable to the Texas underlying properties. VOC Energy Trust was incorporated in 2010 and is based in Houston, Texas.
Earnings Per Share
As for profitability, VOC Energy Trust Units of Beneficial Interest has a trailing twelve months EPS of $1.27.
PE Ratio
VOC Energy Trust Units of Beneficial Interest has a trailing twelve months price to earnings ratio of 7.24. Meaning, the purchaser of the share is investing $7.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 139.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 90.5%, now sitting on 23.59M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 26, 2023, the estimated forward annual dividend rate is 1.25 and the estimated forward annual dividend yield is 13.66%.
Volume
Today’s last reported volume for VOC Energy Trust Units of Beneficial Interest is 120579 which is 31.78% below its average volume of 176763.
Yearly Top and Bottom Value
VOC Energy Trust Units of Beneficial Interest’s stock is valued at $9.19 at 02:23 EST, way below its 52-week high of $13.70 and way above its 52-week low of $5.75.
3. AvalonBay Communities (AVB)
78.33% Payout Ratio
As of December 31, 2022, the Company owned or held a direct or indirect ownership interest in 294 apartment communities containing 88,475 apartment homes in 12 states and the District of Columbia, of which 18 communities were under development and one community was under redevelopment. The Company is an equity REIT in the business of developing, redeveloping, acquiring and managing apartment communities in leading metropolitan areas in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California, as well as in the Company's expansion markets of Raleigh-Durham and Charlotte, North Carolina, Southeast Florida, Dallas and Austin, Texas, and Denver, Colorado.
Earnings Per Share
As for profitability, AvalonBay Communities has a trailing twelve months EPS of $8.44.
PE Ratio
AvalonBay Communities has a trailing twelve months price to earnings ratio of 21.32. Meaning, the purchaser of the share is investing $21.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.24%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AvalonBay Communities’s EBITDA is 59.66.
4. CVR Partners, LP (UAN)
71.37% Payout Ratio
CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea and ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is headquartered in Sugar Land, Texas.
Earnings Per Share
As for profitability, CVR Partners, LP has a trailing twelve months EPS of $27.1.
PE Ratio
CVR Partners, LP has a trailing twelve months price to earnings ratio of 3.47. Meaning, the purchaser of the share is investing $3.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 76.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 835.58M for the twelve trailing months.
5. Eli Lilly and Company (LLY)
56.81% Payout Ratio
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.89.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 58.05. Meaning, the purchaser of the share is investing $58.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.67%.
Sales Growth
Eli Lilly and Company’s sales growth is 12.8% for the present quarter and 12.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 51.2% and 12.1%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Eli Lilly and Company’s EBITDA is 170.6.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.7%, now sitting on 28.54B for the twelve trailing months.
6. Itau Unibanco (ITUB)
31.07% Payout Ratio
Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. is a subsidiary of IUPAR – Itaú Unibanco Participações S.A.
Earnings Per Share
As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.62.
PE Ratio
Itau Unibanco has a trailing twelve months price to earnings ratio of 8.29. Meaning, the purchaser of the share is investing $8.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.98%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 2, 2023, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 4.59%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 21.4% and 6.3%, respectively.
